Saturday, July 24, 2021
ADVT 
International

UN: 'Concerning news' vaccines may not work against variants

Darpan News Desk The Canadian Press, 08 Feb, 2021 06:54 PM
  • UN: 'Concerning news' vaccines may not work against variants

The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it “concerning news” that the vaccines developed so far may be less effective against the variant first detected in South Africa.

Tedros Adhanom Ghebreyesus said at a media briefing that South Africa’s decision on Sunday to suspend its vaccination campaign using the AstraZeneca vaccine is “a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures.”

He said it was increasingly clear that vaccine manufacturers would need to tweak their existing shots to address the ongoing genetic evolution of the coronavirus, saying booster shots would most likely be necessary, especially since new variants of the virus are now spreading globally and appear likely to become the predominant strains.

Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine. That designation would allow millions of doses to be shipped to poor countries as part of a U.N.-backed effort to distribute COVID-19 vaccines worldwide known as COVAX.

Last week, Tedros said that more than three quarters of COVID-19 vaccines had been administered in just 10 countries and that immunization in nearly 130 countries had yet to start. Despite WHO's aim of starting COVID-19 vaccination in poor countries at the same time as wealthy countries, COVAX hasn't delivered any vaccine doses anywhere.

Dr. Soumya Swaminathan, WHO's chief scientist, said people shouldn't conclude from South Africa's decision that the AstraZeneca vaccine doesn't work. She said all of the available evidence to date shows the vaccines developed so far reduce deaths, hospitalizations and severe disease.

Other COVID-19 vaccines developed by Novavax, Pfizer and BioNTech and Johnson & Johnson also appear to be less effective against the strain first identified in South Africa, although they may prevent severe disease.

MORE International ARTICLES

Uneasy calm settles on Capitol after day of chaos

Uneasy calm settles on Capitol after day of chaos

Overnight, just hours after Trump supporters forced their way into the building and terrorized lawmakers, Congress ultimately certified Joe Biden as U.S. president-elect.

Uneasy calm settles on Capitol after day of chaos

Trump supporters mass in D.C. as Biden era begins

Trump supporters mass in D.C. as Biden era begins

Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Fauci: US could soon give 1 million vaccinations a day

Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

Trump call ratchets up political tension in U.S.

That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

'Relieved': US health workers start getting COVID-19 vaccine

Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population